Pediatric Brain Tumor Consortium - Developmental Therapeutics Review - Q4 2010

Global Markets Direct, December 2010, Pages: 67

Pediatric Brain Tumor Consortium – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Pediatric Brain Tumor Consortium – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Pediatric Brain Tumor Consortium.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Pediatric Brain Tumor Consortium with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Pediatric Brain Tumor Consortium’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Identify new drug targets and therapeutic classes in Pediatric Brain Tumor Consortium’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Pediatric Brain Tumor Consortium’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of Pediatric Brain Tumor Consortium in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Pediatric Brain Tumor Consortium.
- Avoid Intellectual Property Rights related issues.

List of Tables
List of Figures
Pediatric Brain Tumor Consortium Snapshot
Pediatric Brain Tumor Consortium Overview
Key Information
Key Facts
Pediatric Brain Tumor Consortium – Research and Development Overview
Key Therapeutic Areas
Pediatric Brain Tumor Consortium – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Pediatric Brain Tumor Consortium – Pipeline Products Glance
Pediatric Brain Tumor Consortium Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Pediatric Brain Tumor Consortium – Drug Profiles
bevacizumab + irinotecan + Radiation theraphy
Product Description
Mechanism of Action
R&D Progress
Biological: cintredekin besudotox|Procedure: conventional surgery
Product Description
Mechanism of Action
R&D Progress
gefitinib + radiation therapy
Product Description
Mechanism of Action
R&D Progress
GW572016
Product Description
Mechanism of Action
R&D Progress
Imatinib + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Imatinib Mesylate + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Iressa + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Lapatinib
Product Description
Mechanism of Action
R&D Progress
lapatinib ditosylate
Product Description
Mechanism of Action
R&D Progress
O6-Benzylguanine + Temozolomide
Product Description
Mechanism of Action
R&D Progress
Oxaliplatin
Product Description
Mechanism of Action
R&D Progress
R115777 + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
tipifarnib + radiation theraphy
Product Description
Mechanism of Action
R&D Progress
TP-38 Toxin
Product Description
Mechanism of Action
R&D Progress
ABT-888 + temozolomide
Product Description
Mechanism of Action
R&D Progress
AZD2171
Product Description
Mechanism of Action
R&D Progress
AZD6244
Product Description
Mechanism of Action
R&D Progress
busulfan
Product Description
Mechanism of Action
R&D Progress
Capecitabine + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
cediranib maleate
Product Description
Mechanism of Action
R&D Progress
cilengitide
Product Description
Mechanism of Action
R&D Progress
EMD 121974
Product Description
Mechanism of Action
R&D Progress
Filgrastim + O6-Benzylguanine + Temozolomide
Product Description
Mechanism of Action
R&D Progress
Laromustine
Product Description
Mechanism of Action
R&D Progress
Lenalidomide
Product Description
Mechanism of Action
R&D Progress
Lenalidomide
Product Description
Mechanism of Action
R&D Progress
LY317615
Product Description
Mechanism of Action
R&D Progress
MK0752
Product Description
Mechanism of Action
R&D Progress
O6-benzylguanine + carmustine
Product Description
Mechanism of Action
R&D Progress
O6-benzylguanine + temozolomide + filgrastim
Product Description
Mechanism of Action
R&D Progress
SCH 66336
Product Description
Mechanism of Action
R&D Progress
semaxanib
Product Description
Mechanism of Action
R&D Progress
topotecan
Product Description
Mechanism of Action
R&D Progress
Topotecan Hydrochloride
Product Description
Mechanism of Action
R&D Progress
VNP40101M
Product Description
Mechanism of Action
R&D Progress
Pediatric Brain Tumor Consortium – Pipeline Analysis
Pediatric Brain Tumor Consortium – Pipeline Products by Therapeutic Class
Pediatric Brain Tumor Consortium Pipeline Products By Target
Pediatric Brain Tumor Consortium – Pipeline Products by Route of Administration
Pediatric Brain Tumor Consortium – Pipeline Products by Molecule Type
Pediatric Brain Tumor Consortium – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Generic Defense Strategies: Lifecycle Management Strategies to Maximize Revenue in the Face of Growing Generic Competition
• Creating the Digital Library, 2012 Edition
• Aerospace and Defense Industry - Global Strategic Business Report
• International Military and Government Helicopter Survey
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Aerospace and Defence Industry - Global Strategic Business Report
• Charter Schools - Global Outlook